Detalles de la búsqueda
1.
Individualized busulfan dosing improves outcomes compared to fixed-dose administration in pre-transplant minimal residual disease-positive acute myeloid leukemia patients with intermediate-risk undergoing allogeneic stem cell transplantation in CR.
Eur J Haematol
; 110(2): 188-197, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36335432
2.
Post-Transplantation Day +100 Minimal Residual Disease Detection Rather Than Mixed Chimerism Predicts Relapses after Allogeneic Stem Cell Transplantation for Intermediate-Risk Acute Myelogenous Leukemia Patients Undergoing Transplantation in Complete Remission.
Transplant Cell Ther
; 28(7): 374.e1-374.e9, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35429661
3.
Peri-transplant flow-MRD assessment of cells with leukemic stem cells (LSC) associated phenotype in AML patients undergoing allogeneic stem cell transplantation in CR.
Leukemia
; 38(2): 386-388, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38263432
4.
Post-transplant immune reconstitution after unrelated allogeneic stem cell transplant in patients with acute myeloid leukemia.
Leuk Lymphoma
; 51(8): 1450-63, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20557144
5.
Kinetics of G-CSF and CD34+ cell mobilization after once or twice daily stimulation with rHu granulocyte-stimulating factor (lenograstim) in healthy volunteers: an intraindividual crossover study.
Transfusion
; 44(1): 104-10, 2004 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-14692975
6.
Influence of anti-thymocyte globulin as part of the conditioning regimen on immune reconstitution following matched related bone marrow transplantation.
J Hematother Stem Cell Res
; 12(2): 237-42, 2003 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-12804182
Resultados
1 -
6
de 6
1
Próxima >
>>